High-dose continuous intravenous infusion of interleukin-2 therapy for metastatic renal cell carcinoma: The university of Chicago experience
Keith L. Shulman, Walter M. Stadler, Nicholas J. VogelzangVolume:
47
Year:
1996
Language:
english
DOI:
10.1016/s0090-4295(99)80414-2
File:
PDF, 506 KB
english, 1996